INOVIO PHARMACEUTICALS, INC. Common Stock, Par or Stated Value Per Share
INOVIO PHARMACEUTICALS, INC. (INO) had Common Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2026-08-12
- 2026-06-30: Common Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-12-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-09-30: Common Stock, Par or Stated Value Per Share $0.00.
| Period end | Common Stock, Par or Stated Value Per Share |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-06 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |